Skip to main content
InSITE: Listing

Volume: 15 Number: 8

Title: Drug Industry Document Archive

Source/Sponsoring Agency: University of California, San Francisco. Library & Center for Knowledge Management

URL: http://dida.library.ucsf.edu/

Date Checked: 11/30/2009      Status: Active

Date Annotated: 11/30/2009

Topics: Food and Drug Law; Law and Medicine

Other keywords: Litigation; Medicine; Merck; Pfizer; Warner-Lambert; Wyeth

Contents: The Drug Industry Document Archive is a collaborative effort of the University of California at San Francisco (UCSF) Library and two UCSF faculty members, Drs Seth Landefeld, MD and Michael Steinman, MD. (The UCSF Library also provides the Tobacco Control Archives annotated in InSITE vol. 10, no. 18). While the project has grown over the years, it has its roots as an archive of the documents pertaining to the United States of America ex rel. David Franklin v. Parke-Davis, Division of Warner-Lambert litigation. In a matter that garnered significant attention, David Franklin, a former employee of Parke-Davis, alleged that the company had violated federal law by systematically marketing the drug Neurontin for uses that were not approved by the Food and Drug Administration. The drug was being pushed as effective for a variety of types of pain, migraine headaches, and bipolar disorder. Landefeld and Steinman, as unpaid expert witnesses for Franklin, submitted a report to the court on the marketing practices for Neurontin and the impact these practices had on physician prescribing. Other documents from the case were obtained from the court and plaintiff’s law firm. The website makes these documents and many others available. Four additional companies are covered by the archive: Merck, Pfizer, Warner-Lambert, and Wyeth. Users of the site may browse by document type or search the archive. Document types include affidavits, brochures, diagrams, e-mails, legal briefs, memos, and marketing reports. The memos are quite interesting as they reveal the inner workings of the drug companies represented. Memos available include those that detail marketing goals for Neurontin and ones that discuss plans for the Merck anti-inflammatory drug, Vioxx. Users may do simple searching, but field searching is also supported. Fields available include, author, document type, date, exhibit number, metadata, and recipient.

Author of Annotation: M. Morrison


Last Modified: 6/20/2012